AHCY and esophageal cancer: Adenosylhomocysteinase is known to promote adenosine-induced apoptosis in HepG2 and esophageal cancer cells, also blocking the motility of the latter, and to inhibit autophagy in osteosarcoma cells in an MTORC1-independent manner [83,84,85].